These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24300725)

  • 1. A low grade PIN-like neoplasm of the transition zone immunohistochemically negative for basal cell markers: a possible example of low grade adenocarcinoma with stratified epithelium.
    Montironi R; Cheng L; Lopez-Beltran A; Montironi MA; Galosi AB; Scarpelli M
    Pathology; 2014 Jan; 46(1):88-91. PubMed ID: 24300725
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer.
    Padmanabhan V; Callas P; Philips G; Trainer TD; Beatty BG
    J Clin Pathol; 2004 Oct; 57(10):1057-62. PubMed ID: 15452160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliable identification of transition zone prostatic adenocarcinoma in preoperative needle core biopsy.
    Lee S; Walsh S; Woods CG; Bonkhoff H; Cohen RJ
    Hum Pathol; 2013 Oct; 44(10):2331-7. PubMed ID: 23954139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcystic adenocarcinoma of the prostate: a variant of pseudohyperplastic and atrophic patterns.
    Yaskiv O; Cao D; Humphrey PA
    Am J Surg Pathol; 2010 Apr; 34(4):556-61. PubMed ID: 20216381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.
    Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO
    Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
    Helpap B; Riede C
    Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Allergic vasculitis in benign prostatic hyperplasia combined with a latent prostatic carcinoma].
    Shmurun RI
    Urol Nefrol (Mosk); 1997; (5):46-9. PubMed ID: 9412017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia.
    Montironi R; Lucarini G; Castaldini C; Galluzzi CM; Biagini G; Fabris G
    Anticancer Res; 1996; 16(4A):2057-62. PubMed ID: 8712742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P; Amin MB; Xu HJ; Linden MD
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of benign and malignant prostatic tumors].
    Dhom G
    Urologe A; 1992 Nov; 31(6):W47-55. PubMed ID: 1281358
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
    Bostwick DG
    Cancer; 1996 Jul; 78(2):330-6. PubMed ID: 8674012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudohyperplastic prostatic adenocarcinoma.
    Humphrey PA; Kaleem Z; Swanson PE; Vollmer RT
    Am J Surg Pathol; 1998 Oct; 22(10):1239-46. PubMed ID: 9777986
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Suspicious acinar proliferations of the prostate].
    Helpap B
    Verh Dtsch Ges Pathol; 1999; 83():162-7. PubMed ID: 10714207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical adenomatous hyperplasia of the prostate mimicking adenocarcinoma lesion: case report and literature review.
    Enciu M; Aşchie M; Boşoteanu M; Chisoi A
    Rom J Morphol Embryol; 2012; 53(4):1093-6. PubMed ID: 23303039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Pim-1 during progression of prostatic adenocarcinoma.
    Cibull TL; Jones TD; Li L; Eble JN; Ann Baldridge L; Malott SR; Luo Y; Cheng L
    J Clin Pathol; 2006 Mar; 59(3):285-8. PubMed ID: 16505280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of morphology in non-neoplastic prostate including cancer mimics.
    Montironi R; Scarpelli M; Mazzucchelli R; Cheng L; Lopez-Beltran A
    Histopathology; 2012 Jan; 60(1):41-58. PubMed ID: 22212077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. My approach to intraductal lesions of the prostate gland.
    Pickup M; Van der Kwast TH
    J Clin Pathol; 2007 Aug; 60(8):856-65. PubMed ID: 17237185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low-stage prostatic adenocarcinoma and atypical lesions of the prostate].
    Maganto Pavón E; García González R; Ruiz Zárate C; Fernández González I; Fernández Fernández A; Vallejo Herrador J; Mateos Torres A; Escudero Barrilero A
    Arch Esp Urol; 1990; 43(9):967-70. PubMed ID: 1708979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.